Nasal septum deviation correlates with asymmetry in Parkinson’s disease
Objective: To assesse whether asymmetry in the nasal cavity is related to dopaminergic dysfunction asymmetry in PD patients Background: Asymmetry in motor dysfunction and associated dopaminergic…The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset
Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.…Role of presenilin 1 variants in parkinsonism
Objective: To characterize presenilin 1 gene (PSEN1) variants which can cause parkinsonism. Background: Variants in PSEN1 are associated with early onset Alzheimer’s disease mainly due…Parkinsonism after Post-Anoxic Brain Injury
Objective: To describe two cases of parkinsonism caused by anoxic brain injury. Background: Movement disorders occur in about 40% of patients following anoxic brain injury,…Atypical Frontotemporal Dementia with Parkinsonism Linked to SQSTM1 Mutation A Clinicopathological Case Study
Objective: To describe the clinical, neuroimaging, and neuropathological features of a patient with frontotemporal dementia (FTD) and parkinsonism related to mutation in the SQSTM1 gene.…Multiscale entropy: a New Oculomotor Measure of PSP.
Objective: The objective of this study was investigate whether multiscale entropy, a measure of complexity, when applied to the path of unconstrained eye movements could…Conjugal Parkinsonism
Objective: To report a case of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a couple. Background: Conjugal parkinsonism denotes an entity where…Wearable Sensor-Based Assessment of Lower Extremity Dystonia in X-linked Dystonia Parkinsonism
Objective: To develop a sensor-based pipeline to identify lower limb dystonic features in X-linked dystonia parkinsonism (XDP). Background: XDP is a rare neurogenetic combined movement…Results from the PRIME-UK Randomised Controlled Trial
Objective: To evaluate whether PRIME-Parkinson care increases the ability of people with parkinsonism (PwP) to achieve their personal goals, has a positive impact on health…Clinical Characteristics of Sporadic Parkinson’s Disease with Negative CSF Alpha-synuclein Seed Amplification Assay
Objective: Define clinical characteristics of individuals with sporadic Parkinson’s disease (sPD) enrolled in the Parkinson’s Progression Markers Initiative (PPMI) who have a negative CSF alpha-synuclein…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 425
- Next Page »
